欧盟EMA药品数据库-欧盟集中审批药品
（European Medicines Agency Authorisation of Medicines DataBase）
请输入需要查询的英文药品名称，通用名称，活性成分，产品号
*Search by Medicine name,INN,Active substance,Product number.
高级搜索
数据记录共 2649 条，共 133 页，当前第 54 页
可点击列名称排序
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Vitekta Human elvitegravir elvitegravir EMEA/H/C/002577 Gilead Sciences International Ltd 2013/11/13 Withdrawn
Corbilta (previously Levodopa/Carbidopa/Entacapone Sandoz) Human levodopa;carbidopa;entacapone levodopa;carbidopa;entacapone EMEA/H/C/002785 Orion Corporation 2013/11/11 Authorised
Grastofil Human filgrastim filgrastim EMEA/H/C/002150 Accord Healthcare S.L.U. 2013/10/18 Withdrawn
Defitelio Human defibrotide defibrotide EMEA/H/C/002393 Gentium S.r.l. 2013/10/18 Authorised
Ovaleap Human follitropin alfa follitropin alfa EMEA/H/C/002608 Theramex Ireland Limited 2013/09/27 Authorised
Giotrif Human afatinib afatinib EMEA/H/C/002280 Boehringer Ingelheim International GmbH 2013/09/25 Authorised
Imatinib medac Human imatinib imatinib EMEA/H/C/002692 Medac 2013/09/25 Withdrawn
Evarrest Human human fibrinogen;human thrombin human fibrinogen;human thrombin EMEA/H/C/002515 Omrix Biopharmaceuticals N. V. 2013/09/25 Withdrawn
Ultibro Breezhaler Human indacaterol;glycopyrronium bromide indacaterol;glycopyrronium bromide EMEA/H/C/002679 Novartis Europharm Limited 2013/09/19 Authorised
Tybost Human cobicistat cobicistat EMEA/H/C/002572 Gilead Sciences Ireland UC 2013/09/19 Authorised
Incresync Human alogliptin;pioglitazone alogliptin;pioglitazone EMEA/H/C/002178 Takeda Pharma A/S 2013/09/19 Authorised
Trifexis Veterinary spinosad;milbemycin oxime spinosad;milbemycin oxime EMEA/V/C/002635 Eli Lilly and Company Limited 2013/09/19 Expired
Xoterna Breezhaler Human indacaterol;glycopyrronium bromide indacaterol;glycopyrronium bromide EMEA/H/C/003755 Novartis Europharm Limited 2013/09/18 Authorised
Vipdomet Human alogliptin;metformin alogliptin benzoate;metformin hydrochloride EMEA/H/C/002654 Takeda Pharma A/S 2013/09/18 Authorised
Vipidia Human alogliptin benzoate alogliptin EMEA/H/C/002182 Takeda Pharma A/S 2013/09/18 Authorised
Lemtrada Human alemtuzumab alemtuzumab EMEA/H/C/003718 Sanofi Belgium 2013/09/12 Authorised
Orphacol Human cholic acid cholic acid EMEA/H/C/001250 Theravia 2013/09/12 Authorised
Remsima Human infliximab infliximab EMEA/H/C/002576 Celltrion Healthcare Hungary Kft. 2013/09/10 Authorised
Inflectra Human infliximab infliximab EMEA/H/C/002778 Pfizer Europe MA EEIG 2013/09/10 Authorised
Provenge Human autologous peripheral-blood mononuclear cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor (sipuleucel-T) autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor EMEA/H/C/002513 Dendreon UK Ltd 2013/09/06 Withdrawn

数据库说明：

©2006-2025 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase